Over‐expressed MEG3 was found to impair viability of MDA‐MB‐231 and MCF‐7 cell lines (P < .05), while lowly expressed MEG3 reinforced viability of the BC cells to 1.73‐2.16 times of control group (P < .05) (Figure 3A). The gene discussed is MEG3; the disease is breast cancer.